Evercore ISI analyst Robert Ottenstein raised the firm’s price target on Procter & Gamble to $170 from $160 and keeps an Outperform rating on the shares. Fiscal Q3 "proved to be the statement quarter we expected the June quarter to be," the analyst tells investors, adding that strong momentum in sales and the upswing in margins should drive FY24 earnings.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PG:
- P&G Stock (NYSE:PG): Why I’m Not Buying Despite Strong Q3 Earnings
- Procter & Gamble price target raised to $175 from $171 at Jefferies
- Procter & Gamble price target raised to $170 from $160 at Deutsche Bank
- Procter & Gamble price target raised to $174 from $160 at Morgan Stanley
- Procter & Gamble price target raised to $175 from $170 at Raymond James
